Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
A red flag: a COA from a third-party lab you cannot independently verify via the lab's own website or accreditation database
M.HartmannB.Sparre-UlrichA
Submits FDA Filing July 14, 2022 26th worldwide patent and the first patent issued from Lexarias seventh patent family Lexarias Human Nicotine Study Nearing Start Date July 13, 2022 Lexaria is targeting the oral nicotine pouch category, one of the fastest growing segments of the nicotine industry Lexaria Granted Patent for Use of DehydraTECH to Deliver Antiviral Drugs April 21, 2022 25th patent grant is Lexarias first-ever patent for the enhanced delivery of antivirals Lexarias Pulmonary Hypertension Clinical Study HYPER-H21-3 Delivers Positive Results April 14, 2022 Data From This Human Study, Together With the Findings From Lexarias Other Previously Announced Successful Studies, Intended To Support the Companys Plans To Seek Approvals by the U.S
The reconstitution volume sets the concentration of all four peptides proportionally
Through the program, Sesame clinicians collect a detailed medical history from each patient and help patients with appropriate diet, exercise and lifestyle modifications
US$ 24.02
US$ 29.00
US$ 21.75
US$ 20.87
US$ 28.35
